Youngy Health Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	857.27	681.18	521.77	453.79	516.31	508.07
Other Revenue	7.61	7.61	7.68	9.53	10.19	6.01
Revenue	864.89	688.79	529.45	463.32	526.5	514.08
Revenue Growth (YoY)	37.05%	30.10%	14.27%	-12.00%	2.42%	-29.59%
Cost of Revenue	555.93	472.78	363.03	354.61	408.31	382.08
Gross Profit	308.95	216.01	166.42	108.71	118.19	132
Selling, General & Admin	166.46	135.12	119.56	105.05	97.46	117.38
Research & Development	12.24	11.7	9.06	10.97	13.52	13.41
Other Operating Expenses	6.42	4.82	4.8	4.6	3.94	3.9
Operating Expenses	186.82	153.2	133.48	121.52	105.9	119.61
Operating Income	122.13	62.81	32.94	-12.81	12.29	12.39
Interest Expense	-	-	-	-0	-	-0.76
Interest & Investment Income	14.07	16.53	11.88	136	9.74	0.78
Currency Exchange Gain (Loss)	3.06	3.06	2.34	9.05	-3.45	-10.15
Other Non Operating Income (Expenses)	-1.2	-0.98	-1.8	-0.18	1.09	-1.46
EBT Excluding Unusual Items	138.06	81.42	45.36	132.05	19.66	0.8
Gain (Loss) on Sale of Investments	0.98	5.66	13.32	3.38	15.86	-48.58
Gain (Loss) on Sale of Assets	-0.13	0.01	-0.5	0.59	0.03	-0.14
Asset Writedown	-0.86	-0.95	-0.38	-0.31	0.03	-3.78
Other Unusual Items	4.22	2.01	1.96	0.68	2.19	6.13
Pretax Income	142.27	88.15	59.76	136.39	37.77	-45.56
Income Tax Expense	34.85	22.1	17.84	3.06	6.32	9.72
Earnings From Continuing Operations	107.42	66.06	41.92	133.33	31.45	-55.28
Minority Interest in Earnings	-30.47	-19.2	-15.34	-7.02	-7.25	-10.45
Net Income	76.95	46.85	26.58	126.31	24.2	-65.73
Net Income to Common	76.95	46.85	26.58	126.31	24.2	-65.73
Net Income Growth	106.12%	76.26%	-78.95%	421.87%	-	-
Shares Outstanding (Basic)	781	781	886	789	807	822
Shares Outstanding (Diluted)	781	781	886	789	807	822
Shares Change (YoY)	-11.79%	-11.87%	12.24%	-2.15%	-1.81%	2.12%
EPS (Basic)	0.10	0.06	0.03	0.16	0.03	-0.08
EPS (Diluted)	0.10	0.06	0.03	0.16	0.03	-0.08
EPS Growth	133.67%	100.00%	-81.25%	433.33%	-	-
Free Cash Flow	68.15	42.2	80.53	-46.72	4.6	72.28
Free Cash Flow Per Share	0.09	0.05	0.09	-0.06	0.01	0.09
Gross Margin	35.72%	31.36%	31.43%	23.46%	22.45%	25.68%
Operating Margin	14.12%	9.12%	6.22%	-2.77%	2.33%	2.41%
Profit Margin	8.90%	6.80%	5.02%	27.26%	4.60%	-12.79%
Free Cash Flow Margin	7.88%	6.13%	15.21%	-10.08%	0.87%	14.06%
EBITDA	154.6	88.74	50.16	5.45	29.49	30.98
EBITDA Margin	17.88%	12.88%	9.47%	1.18%	5.60%	6.03%
D&A For EBITDA	32.47	25.93	17.22	18.27	17.2	18.58
EBIT	122.13	62.81	32.94	-12.81	12.29	12.39
EBIT Margin	14.12%	9.12%	6.22%	-2.77%	2.33%	2.41%
Effective Tax Rate	24.50%	25.07%	29.85%	2.25%	16.73%	-
Revenue as Reported	864.89	688.79	529.45	463.32	526.5	514.08
Advertising Expenses	-	11.26	8.01	7.84	6.1	16.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.